Group One Trading
JBIO

Group One Trading’s Jade Biosciences JBIO Stock Holding History

Group One Trading’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,889
Closed -$2.22M – 7570
2024
Q4 		$2.22M Buy
23,889
+23,112
+2,975% +$1.99M 0.01% 1821
2024
Q3 		$56.8K Buy
+777
New +$50.1K ﹤0.01% 4567

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Group One Trading's JBIO Position: Q2 2026 in Review

Group One Trading reduced its Jade Biosciences (JBIO) stake by 50% in Q2 2026, selling an estimated $42 and leaving 2 shares worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #7434.

Group One Trading first reported a position in JBIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $371K in Q4 2024. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Group One Trading held 2 shares of Jade Biosciences worth $44 as of Q2 2026.
  • Group One Trading sold 2 Jade Biosciences shares in Q2 2026, an estimated $42.
  • Jade Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7434 holding.
  • Group One Trading first reported a position in Jade Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Group One Trading's Jade Biosciences position peaked at $371K in Q4 2024.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.